Introduction
Though clinically significant, impairment of hepatic function is unusual in shock, a transient (5-25 days) , and often marked (10-300 times the upper limit of normal) change in serum enzyme levels in association with centrilobular hepatic necrosis has been described (1) (2) (3) (4) (5) (6) (7) (8) (9) . Historically referred to as "shock liver", clinical and experimental reports over the last five decades have confirmed that the liver is a target organ during certain hypotensive states (10) (11) (12) . More recent reports have focused on hepatic dysfunction resulting from passive congestion (e.g., heart failure), termed ischemic hepatitis, or hypoxic insult (e.g., respiratory failure), termed hypoxic hepatitis (3, (13) (14) (15) (16) . Although the pathogenesis is multifactorial, the final common pathway is hepatocellular dysfunction secondary to critically low levels of oxygen for metabolic processes. We conducted a 13-year retrospective review of the pattern of serum enzyme changes in 293 critically ill patients involving 322 episodes to describe the characteristics of hypoxic hepatopathy.
Materials and Methods

Study patients
We reviewed the medical records of 293 [2] (e.g., hypotension), decreased oxygen availability [3] (e.g., sepsis) and increased oxygen consumption [4] (e.g., hyperthermia).
Data collection
Hypotension was defined as, 1) (Fig. 1) (18) , but most subsequent work has been performed in animal models of shock (10, 11, 19, 20) 
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. Human studies have, until recently, not made any distinction between the relative contributions of passive congestion, circulatory failure and hypoxia and the patterns of abnormal enzymes observed in these patients (21, 22, 42). The reported etiologies include: primary heart disease (78%), congestive heart failure (65%), acute myocardial infarction (17%), chronic respiratory failure (12%), circulatory shock and/or sepsis (15%). Severe hypotension or shock was reported in 61% of patients (range 31-100%) (4, 6, 9, 12, 16, 21-23). The mean in-hospital mortality was 52.2%. Richman and coworkers (24) further detailed abnormalities of liver function tests in cases of chronic congestive heart failure and reported a fall in albumin and elevations of globulin, prothrombin time, bilirubin, alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase.
Additionally, there were a number of reports of fulminant "hepatitis" or hepatic failure in the presence of acute congestive heart failure (1, 4, 25, 26) . However, the absence of shock, passive congestion, or acute myocardial infarction is assured in only one report (4) . Yet, several studies concluded from their investigations that ischemic liver damage was rare secondary to acute congestive heart failure and that profound and prolonged shock was usually necessary for the development of "shock liver" (9, 27, 28 mo g r a p h i c , Cl i n i c a l a n d L a b o r a t o r 
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quence of hypoperfusion (38) . Laparoscopic colectomy and laparoscopic cholecystectomy have been associated with subclinical hepatocyte dysfunction, presumably due to increased intra-abdominal pressure, patient positioning and the neurohumoral response to surgical stress (39) . Profound hepatic hypoperfusion (66% reduction of portal flow during ischemia and 80% reduction in hepatic artery flow during reperfusion) producing temporary acute hepatic dysfunction has been found to follow intestinal ischemia-reperfusion injury in the rat (40) . In the pig model the reduction of aortic blood flow by cardiac tamponade can exhaust the hepatic arterial buffer response resulting in hepatic dysfunction without signs of cellular damage (41) .
The original work of Dunn et al identified 3 hypothetical mechanisms for hypoxic injury to the liver in the setting of CHF: venous congestion secondary to RVF, ischemia due to decreased hepatic blood flow, and hypoxemia due to decreased oxygen in the hepatic artery (42) . The results of this study and those of others (16, 22) The prognosis of a patient with ischemic liver damage depends on the prognosis of the underlying disease (37) . None of the patients in the reported series developed fulminant hepatic failure. Liver biopsy is not necessary for diagnosis and
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prognosis is largely independent of the subclinical illness. However, the occurrence of hypoxic hepatopathy is a harbinger of a potentially poor prognosis since the mortality rate varies from 25-73% (6, 16, 22) .
Conclusion
Hypoxic injury to the liver is a reversible subclinical condition occurring in at least 1% of critically ill patients and accounting for over 50% of dramatic serum aminotransferase activity (24- 
